Team:Paris Bettencourt
From 2013.igem.org
(Difference between revisions)
Line 32: | Line 32: | ||
margin-top:50px; | margin-top:50px; | ||
margin-bottom:50px; | margin-bottom:50px; | ||
+ | color: rgb(30,39,43); | ||
font-family: 'Yanone Kaffeesatz', sans-serif; | font-family: 'Yanone Kaffeesatz', sans-serif; | ||
} | } | ||
Line 51: | Line 52: | ||
line-height:244px; | line-height:244px; | ||
text-align:center; | text-align:center; | ||
+ | } | ||
+ | .subpanel2 a { | ||
+ | color: rgb(30,39,43); | ||
} | } | ||
.subpanel2:hover{ | .subpanel2:hover{ |
Revision as of 21:29, 5 September 2013
Using Escherichia coli as a model organism we are developing different approaches that can contribute to the eradication of tuberculosis.
A phage system that detects the presence of sequence specific antibiotic resistance genes.
A safe and specific drug screening method that targets essential mycobacterial metabolic proteins.
A stable phage system producing sRNA which inhibit the production of antibiotic resistance proteins.
An E. coli which invade macrophages and kill mycobacteria.
Visit our Achievements!